Faruqi & Faruqi Urges Baxter Investors to Represent in Class Action Lawsuit Before December Deadline

Urgent Reminder for Baxter Investors: Class Action Lawsuit Deadline Approaches

Faruqi & Faruqi, a prominent national law firm specializing in securities litigation, has issued a crucial reminder to investors of Baxter International Inc. regarding the upcoming deadline for participating in a class-action lawsuit. Those who acquired Baxter securities between February 23, 2022, and July 30, 2025, must act before December 15, 2025, to seek the role of lead plaintiff in this case.

Background on Baxter's Allegations

The claims against Baxter International revolve around serious accusations of violating federal securities laws. Investors allege that the company and its executives misrepresented important information about their products, particularly the Novum LVP (Large Volume Pump). Reports have surfaced indicating that this medical equipment suffers from systemic defects that have led to malfunctions, posing life-threatening risks to patients. Issues reported include underinfusion, overinfusion, and complete non-delivery of fluids, all of which have resulted in severe injuries and even deaths.

Baxter’s management allegedly knew about these malfunctions yet failed to disclose critical safety issues to investors. Instead of effectively addressing these defects, the company’s attempts through customer alerts were deemed insufficient, failing to mitigate the design flaws that persistently put lives at risk. Furthermore, it was revealed that Baxter paused shipments and installations of the Novum LVP on July 31, 2025, causing a dramatic 22.4% drop in its stock price within a single day.

Implications for Investors

The implications of this case are significant for current Baxter investors, especially those who have incurred losses during the specified period. Faruqi & Faruqi’s partner, James (Josh) Wilson, has been vocal in encouraging affected investors to reach out. This class action lawsuit serves not only as a legal recourse for shareholders who feel defrauded but also as a means to hold Baxter accountable for its alleged negligence and misconduct.

The role of a lead plaintiff is crucial in class action lawsuits as this individual will monitor and direct the litigation on behalf of the entire class, embodying the interests and rights of all involved. Those who wish to be represented have the option to join forces with the law firm or independently through their counsel. This choice does not diminish their ability to receive a share of any settlements or relief that may arise from the lawsuit.

Call to Action for Affected Individuals

Faruqi & Faruqi is extending an invitation to anyone impacted by this situation to engage in dialogue, including whistleblowers, former employees, and other stakeholders who can contribute valuable information about Baxter's operations. For further details, interested parties can visit Faruqi & Faruqi’s dedicated Baxter page or contact the firm directly at 877-247-4292.

Moreover, staying aware of developments regarding this lawsuit can be vital for investors seeking to protect their financial interests. Investors can follow updates through Faruqi & Faruqi’s social media pages to stay informed.

Conclusion

In conclusion, the deadline for Baxter investors to act in this class action lawsuit is fast approaching. With serious allegations of fraud and negligence levied against the company, it is essential for affected individuals to take proactive measures to ensure their voices are heard. The upcoming deadline serves as a pivotal opportunity to seek justice and potentially recover losses incurred as a result of Baxter’s alleged shortcomings. Please ensure that you or someone you know makes a decision regarding participation before the deadline of December 15, 2025.